MCM
Monarch Capital Management Portfolio holdings
AUM
$372M
1-Year Return
16.01%
This Quarter Return
+3.47%
1 Year Return
+16.01%
3 Year Return
+49.32%
5 Year Return
+101.83%
10 Year Return
+222.44%
AUM
$268M
AUM Growth
+$3.85M
(+1.5%)
Cap. Flow
-$2.14M
Cap. Flow
% of AUM
-0.8%
Top 10 Holdings %
Top 10 Hldgs %
31.9%
Holding
101
New
1
Increased
20
Reduced
47
Closed
4
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$1M |
| 2 |
Apple
AAPL
|
+$641K |
| 3 |
Zimmer Biomet
ZBH
|
+$523K |
| 4 |
WLL
Whiting Petroleum Corporation
WLL
|
+$171K |
| 5 |
Flowserve
FLS
|
+$108K |
Top Sells
| 1 |
Coca-Cola
KO
|
+$948K |
| 2 |
Vodafone
VOD
|
+$488K |
| 3 |
GE Aerospace
GE
|
+$409K |
| 4 |
Steel Dynamics
STLD
|
+$335K |
| 5 |
Lakeland Financial Corp
LKFN
|
+$303K |
Sector Composition
| 1 | Healthcare | 22.72% |
| 2 | Industrials | 14.8% |
| 3 | Consumer Staples | 13.58% |
| 4 | Financials | 13.01% |
| 5 | Technology | 12.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abbott
ABT
$225B
| $4.23M | 1.58% |
110,098
+2,400
| +2% | +$92.2K |
|
27
Cincinnati Financial
CINF
$23.8B
| $4.14M | 1.54% |
54,595
-1,202
| -2% | -$91.1K |
|
28
Pfizer
PFE
$141B
| $4.11M | 1.53% |
133,246
-305
| -0.2% | -$9.4K |
|
29
Philip Morris
PM
$261B
| $4.01M | 1.5% |
43,875
| – | – |
|
30
Stryker
SYK
$146B
| $3.73M | 1.39% |
31,147
-850
| -3% | -$102K |
|
|
31
Zimmer Biomet
ZBH
$20.7B
| $3.61M | 1.35% |
36,038
+5,219
| +17% | +$523K |
|
|
32
Flowserve
FLS
$7.41B
| $3.44M | 1.28% |
71,614
+2,254
| +3% | +$108K |
|
|
33
Steel Dynamics
STLD
$19.5B
| $3.38M | 1.26% |
94,849
-9,421
| -9% | -$335K |
|
34
Aflac
AFL
$57.3B
| $3.32M | 1.24% |
95,372
+2,568
| +3% | +$89.4K |
|
35
AT&T
T
$211B
| $3.23M | 1.21% |
100,584
+332
| +0.3% | +$10.7K |
|
36
NextEra Energy, Inc.
NEE
$147B
| $3.09M | 1.15% |
103,452
+400
| +0.4% | +$11.9K |
|
37
Vanguard FTSE Emerging Markets ETF
VWO
$100B
| $2.99M | 1.11% |
83,421
-6,739
| -7% | -$241K |
|
38
Chevron
CVX
$318B
| $2.8M | 1.04% |
23,767
-285
| -1% | -$33.5K |
|
|
39
Gilead Sciences
GILD
$146B
| $2.73M | 1.02% |
38,079
+14,014
| +58% | +$1M |
|
40
PepsiCo
PEP
$197B
| $2.6M | 0.97% |
24,860
-20
| -0.1% | -$2.09K |
|
|
41
Apple
AAPL
$3.41T
| $2.41M | 0.9% |
83,224
+22,140
| +36% | +$641K |
|
42
JPMorgan Chase
JPM
$840B
| $2.39M | 0.89% |
27,702
-250
| -0.9% | -$21.6K |
|
43
Schlumberger
SLB
$54B
| $2.34M | 0.87% |
27,844
-125
| -0.4% | -$10.5K |
|
|
CLC
44
DELISTED
Clarcor
CLC
| $2.21M | 0.83% |
26,825
| – | – |
|
45
Northern Trust
NTRS
$24.2B
| $2.03M | 0.76% |
22,799
-850
| -4% | -$75.7K |
|
46
Genuine Parts
GPC
$19.4B
| $2M | 0.74% |
20,881
-18
| -0.1% | -$1.72K |
|
47
Jacobs Solutions
J
$17.3B
| $1.9M | 0.71% |
40,213
-832
| -2% | -$39.2K |
|
|
48
Vodafone
VOD
$28.6B
| $1.72M | 0.64% |
70,527
-19,993
| -22% | -$488K |
|
49
Bristol-Myers Squibb
BMY
$96B
| $1.69M | 0.63% |
28,919
-2,750
| -9% | -$161K |
|
50
BP
BP
$88.8B
| $1.68M | 0.63% |
52,412
-2,141
| -4% | -$68.5K |
|